JWH-250
JWH-250 is a synthetic cannabinoid receptor agonist from the naphthoylindole family, discovered by John W. Huffman at Clemson University. It is used in scientific research and has been sold online as a designer drug.
Chemistry[edit | edit source]
JWH-250 was discovered by, and named after, Dr. John W. Huffman. It is a synthetic cannabinoid, specifically a naphthoylindole, which acts as a potent but non-selective full agonist for the cannabinoid receptor. It was first synthesized in the mid-1990s for research purposes.
Effects[edit | edit source]
The effects of JWH-250 can be similar to those of natural cannabis but it can also produce significantly different effects. Its effects are mainly mediated by its action on the cannabinoid receptors in the brain.
Legal Status[edit | edit source]
JWH-250 is a controlled substance in several countries including the United States and European Union.
See Also[edit | edit source]
References[edit | edit source]
JWH-250 Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD